LUNGevity Foundation announced a parternship with the ALK Positive patient group to support the new ALK-Positive Lung Cancer Transformational Research Award Program.
In the absence of the federal funding, cancer research will be leaning on private funders. But few private funders have the freedom to ask fundamental questions—questions whose answers may not have an immediate clinical impact but can dramatically advance scientific knowledge.
